Literature DB >> 3487551

The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies.

Y Shoenfeld, O Ben-Yehuda, Y Napartstek, Y Wilner, R Frolichman, A Schattner, G Lavie, H Joshua, J Pinkhas, R C Kennedy.   

Abstract

The sera of 265 patients with monoclonal gammopathies were examined for the presence of a dominant idiotype of the anti-DNA antibody [16/6 idiotype (Id)] and for anti-DNA activity. An enzyme-linked immunosorbent assay (ELISA) with a rabbit anti-16/6 antibody revealed 23 (8.7%) sera that contained increased concentrations of the idiotype. Seven of the patients had benign monoclonal gammopathy, three multiple myeloma, three Waldenström macroglobulinemia, five essential mixed cryoglobulinemia, and five monoclonal cryoglobulinemia. In 5 of the 23 sera, antinuclear activity was also noted. In 11 of the 16/6 Id-positive sera the anti-nucleic acid antibody reactions were found to be polyspecific, reacting with polydeoxythymidilic acid and polyinosinic acid, in addition to single-stranded DNA and double-stranded DNA. Similar results were achieved with the purified serum monoclonal components. The specificity of the idiotype analysis was demonstrated with an unrelated dominant idiotype of anti-HBsAg antibody. In none of the patients, except one (with essential mixed cryoglobulinemia), was lupus symptomatology noted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487551     DOI: 10.1007/BF00918699

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties.

Authors:  J KRITZMAN; H G KUNKEL; J MCCARTHY; R C MELLORS
Journal:  J Lab Clin Med       Date:  1961-06

Review 2.  Immunologic and genetic factors in autoimmune diseases.

Authors:  Y Shoenfeld; R S Schwartz
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

Review 3.  Studies on natural antibodies and autoantibodies.

Authors:  S Avrameas; G Dighiero; P Lymberi; B Guilbert
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

Review 4.  Genetics, expression, and function of idiotypes.

Authors:  K Rajewsky; T Takemori
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  A highly conserved determinant on human rheumatoid factor idiotypes defined by a mouse monoclonal antibody.

Authors:  J L Pasquali; A Urlacher; D Storck
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

6.  Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen.

Authors:  R C Kennedy; G R Dreesman
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations.

Authors:  G Dighiero; B Guilbert; J P Fermand; P Lymberi; F Danon; S Avrameas
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

8.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies.

Authors:  Y Naparstek; D Duggan; A Schattner; M P Madaio; F Goni; B Frangione; B D Stollar; E A Kabat; R S Schwartz
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

Review 2.  Hypergammaglobulinaemia and autoimmune rheumatic diseases.

Authors:  M R Ehrenstein; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 3.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

4.  Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle.

Authors:  H A Teplizki; B Sela; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens.

Authors:  D Buskila; M Abu-Shakra; H Amital-Teplizki; A R Coates; M Krupp; S Sukenik; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

6.  The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies.

Authors:  M Abu-Shakrah; M Krupp; S Argov; D Buskila; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

7.  A cross-reactive idiotype on anti-DNA and lymphocytotoxic antibodies.

Authors:  P M Lydyard; D Isenberg; B de Sousa; L Mackenzie; A Cooke
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

8.  Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide.

Authors:  Y Shoenfeld; Y Vilner; T Reshef; A Klajman; A Skibin; O Kooperman; R C Kennedy
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

9.  The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies).

Authors:  N Yativ; D Buskila; M Blank; C L Burek; N R Rose; Y Shoenfeld
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

10.  Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.